SCHEMBL20622007

SCHEMBL20622007

COC(=O)CCc1ccc(O)c(-n2nc3cc4ccccc4cc3n2)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RPS6KB2 Q9UBS0 2/20 0.45
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
RAB9A P51151 1/20 0.43
PTPN1 P18031 4/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 1/20 0.41
APP P05067 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
ALOX5 P09917 1/20 0.40
OR51E2 Q9H255 1/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
PPARG P37231 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5693424 0.93 LMNA (0.51) NPC1LMNARAB9APTPN1KDM4E
SCHEMBL20599212 0.86 CYP1A2 (0.46) RPS6KB2NPC1LMNARAB9AKDM4E
SCHEMBL9580856 0.85 EGFR (0.43) NPC1LMNARAB9AKDM4EPOLB
SCHEMBL20598749 0.83 APP (0.45) NPC1LMNARAB9AKDM4EPOLB
SCHEMBL5693442 0.82 FFAR4 (0.40) NPC1LMNARAB9AKDM4EPOLB
SCHEMBL20598275 0.82 PLA2G4A (0.41) RPS6KB2NPC1LMNARAB9AKDM4E
SCHEMBL20622005 0.82 CNR2 (0.42) LMNAKDM4EPOLBALDH1A1HPGD
SCHEMBL20598746 0.78 BCHE (0.36) LMNAKDM4EPOLBAPPALDH1A1
SCHEMBL31361788 0.78 NPC1 (0.49) NPC1LMNARAB9AKDM4EPOLB
Naphthalene SCHEMBL5397697 0.78 APP (0.59) LMNAPTPN1KDM4EPOLBAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975040-B2 Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light JOHNSON & JOHNSON VISION CARE, INC. (US) 2021-04-13 US disclosed
US-20190002415-A1 HYDROXYPHENYL NAPHTHOTRIAZOLES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT JOHNSON & JOHNSON VISION CARE, INC. 2019-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975040-B2 Hydroxyphenyl naphthotriazoles as polymerizable blockers of high energy light HRH3, HMGB3, CRYAB RPS6KB2 4314/4885NPC1 3496/4885LMNA 1100/4885
US-20190002415-A1 HYDROXYPHENYL NAPHTHOTRIAZOLES AS POLYMERIZABLE BLOCKERS OF HIGH ENERGY LIGHT HRH3, HMGB3, CRYAB RPS6KB2 4314/4885NPC1 3496/4885LMNA 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.